This week, a scientific panel issued a report that questioned the Food and Drug Administration’s (FDA) decision to rule that bisphenol A (BPA) was safe to be used in plastic products such as baby bottles and food and drinks containers.

Scientists stated the FDA had overlooked major pieces of evidence concerning the chemical’s safety, which might have rendered federal regulators to rule otherwise. Moreover, the Administration came into much criticism for the methods they appealed to in order to make a decision with regards to BPA, the report deeming them as having been deeply flawed.

The FDA is scheduled to review the scientific report this Friday, October 31.

So far, they have released a statement that read the aforementioned reported indeed raised worth looking into questions, but it also added that federal health officials stood by their ruling. Nevertheless, the FDA admitted to the fact that further tests and studies were necessary concerning the BPA safety issue.

The report claimed, among other things, that the FDA had conducted their research on a too small number of baby-formula samples, the result being based more on averages. Moreover, federal regulators allegedly did not take into account animal studies showing that BPA exposure could do harm to the animals.

Scientists also requested that the Administration take into consideration research concerning bisphenol A that had been made public after they had ruled on the chemical's safety matter.

The panel of scientific advisers who reviewed the FDA’s decision comprised environmental health, toxicology and statistics experts from three major universities, alongside the Environmental Protection Agency (EPA) and the Centers for Disease Control and Prevention (CDC).